Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a license and distribution agreement with CSL Seqirus (ASX:CSL) for the exclusive rights to commercialize NEXLETOL ® (bempedoic ...

Under RFK Jr., HHS has canceled key vaccine meetings. Here's what that means for seasonal flu, bird flu, and childhood ...

CSL Seqirus has agreed to provide 665,000 doses of a bird flu vaccine to the European Commission as part of the EU’s efforts to prepare for a potential outbreak of the disease, with an option to ...

As one of the world's largest manufacturers of influenza vaccines, CSL Seqirus is on the front lines in the fight against avian influenza. In fact, the federal government's Biomedical Advanced ...

Total Revenue Grew 186% Y/Y to $332.3 Million; FY24 U.S. Net Product Revenue Grew 48% Y/Y to $115.7 Million ––Q4 Total Revenue Grew 114% ...

The contract covers more than 5 million doses of a CSL Seqirus H5 influenza shot, according to a government statement, which said the vaccines would be manufactured by the company's UK subsidiary.

Australia-based CSL Seqirus is one of the largest influenza vaccine manufacturers in the world, with a major facility in Holly Springs that supports more than 1,000 jobs. Working for such a large ...

The Australian sharemarket ended lower, tracking steep declines on Wall Street and in China, as investors braced for new US ...

HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...

Dec. 13, 2024 — Influenza or flu virus remains infectious in refrigerated raw milk for up to five days, according to a new study. The findings come at a time when outbreaks of bird flu -- a ...

Backyard Poultry Face Bird Flu Risk When Migrating Mallards Stop to Rest Feb. 24, 2025 — Knowing where, when and for how long mallard ducks -- natural carriers of avian influenza -- stop and ...